Avidity Biosciences
RNA
#1825
Rank
HK$84.23 B
Marketcap
HK$559.08
Share price
-0.14%
Change (1 day)
119.76%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: HK$84.23 Billion

As of December 2025 Avidity Biosciences has a market cap of HK$84.23 Billion. This makes Avidity Biosciences the world's 1825th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$84.23 B202.05%
2024HK$27.88 B398.36%
2023HK$5.59 B-51.43%
2022HK$11.52 B32.57%
2021HK$8.69 B17.08%
2020HK$7.42 B

End of Day market cap according to different sources

On Dec 17th, 2025 the market cap of Avidity Biosciences was reported to be:

HK$84.23 Billion
by Nasdaq info icon info icon
HK$84.23 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
HK$46.80 B-44.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
HK$6.38 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$17.23 B-79.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
HK$22.94 B-72.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$0.94 B-98.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
HK$85.03 B 0.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.107 T 1,214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$764.42 B 807.45%๐Ÿ‡ฌ๐Ÿ‡ง UK